IT
$228.79 at the check
LONG

Kairon's answer on IT: leaning up.

Checked Nov 1, 2026 at $228.79, time frame 3-6 months, confidence high
Why? For, against, what would change it
  • ForThe company has strong profit growth, robust cash flow ($1.05bn TTM), and reduced shares outstanding by 19.9% in 3 years.
  • AgainstStock price is 15.3% above analyst mean target, with negative equity (-$2.60/share) and liquidity (current ratio 0.88) concerns.
  • What would change the pictureBullish view breaks if stock closes below $196 or forward EPS estimates drop by more than 5% in the next quarter.
Result check on Apr 30, 2027: open.

The 10-second check

Loading filings…

Both sides

More for

The combination of material upward estimate revisions, strong profit growth, and a PEG below 1 signals the stock is pricing in less than linear growth for its forward multiple—rare for double-digit compounders.

The company consistently generates strong, real cash and funnels it directly into aggressive buybacks—reducing the share base nearly 20% in three years.

More against

Negative equity exposes IT to loss of market/trade credit, higher financing costs, or future solvency risk if cash flow falls.

When price exceeds mean analyst targets by >15% and dispersion remains wide, it signals consensus is uncertain or lagging—reversion to consensus is common after extended runs, especially absent new catalysts.

Read the full debate between the bull and the bear analyst

Bull Analyst: BULL CASE ARGUMENTS

---

Argument 1 – Valuation vs Growth [HIGH conviction]
Evidence: PEG ratio 0.91 (<1 is attractive), Forward P/E 13.96 vs TTM P/E 20.69 (down due to buybacks and earnings growth), 13.4% EPS growth and 4% forward revenue growth expected, analyst EPS 90d revisions: +5.6% (FY) and +7.1% (next year).
Thesis: The combination of material upward estimate revisions (+5.6%–7.1% in just 3 months), strong profit growth (EPS +13.4% ahead), and a PEG below 1 signals the stock is pricing in less than linear growth for its forward multiple—rare for double-digit compounders. The share count down 19.9% over 3y further amplifies per-share value, making the price reasonable for the embedded growth. This is a classic “growth at a reasonable price” setup in a quality earner.

---

Argument 2 – Earnings Quality & Buybacks [HIGH conviction]
Evidence: TTM Free Cash Flow $1.05bn (robust), FCF margin converting a high portion of earnings, 19.9% reduction in shares outstanding over 3 years, last 4 quarterly earnings beats: +13.7%, +12.2%, +13.6%, +17.1%.
Thesis: The company consistently generates strong, real cash (not just accounting profits) and funnels it directly into aggressive buybacks—reducing the share base nearly 20% in three years. This buyback pace is highly accretive, as shown in persistent double-digit quarterly earnings surprises, and provides a reliable floor for per-share value even in the absence of rapid topline growth.

---

Argument 3 – Trend & Momentum Confirmation [HIGH conviction]
Evidence: Price is +35.1% above 200SMA and +16.6% above 50SMA; RSI 66.2 (bullish), MACD well above signal line, price making higher highs/lows for 3+ weeks; VWMA below price with rising volume on up days; Quant: Relative Strength +100, MA ratios +99/+99, ADX +97.
Thesis: The technical setup is classic sustained leadership—massive trend strength and “breadth”, confirmed by both price structure and volume-based algorithmic metrics. In bull market regimes (SPY +4.1% above 200MA), trend-following edges are often persistent; quant signals reinforce—relative strength and moving average signals near max. This is a setup where prudent investors “ride winners”—not fight them.

---

Argument 4 – Market Regime/Statistical Profile [MEDIUM conviction]
Evidence: SPY is +4.1% above 200MA (bull regime); stock: annualized Sharpe 1.47, Sortino 3.01 (strong risk-adjusted returns); quant composite +21/100 (bullish), HMM P(bull) 0.93, volatility compressed (20d/120d ratio 0.74), current drawdown -10.1%.
Thesis: With the broad market in a confirmed bull regime and the stock delivering strong risk-adjusted returns, odds statistically favor trend continuation. Volatility is not excessive relative to trailing norms, and quant risk metrics (Sharpe/Sortino) imply attractive return per unit risk for trend followers.

---

Argument 5 – Short Interest as Squeeze Fuel [LOW conviction]
Evidence: Short ratio 7.11 days, 14.8% of float shorted; price action is up 35%+ off 200SMA despite this.
Thesis: While elevated short interest highlights crowd skepticism, the stock’s ability to rally robustly despite this points to a potential squeeze dynamic if momentum continues. Any exogenous positive news or another earnings beat could accelerate a forced-covering cycle, accentuating upside.

---

BEAR COUNTER-ARGUMENTS

---

Bear said: “Negative equity (book value -$2.60/share) and liquidity (current ratio 0.88) are red flags for solvency.”
Counter:
- The negative equity is the mathematical result of outsized, accretive buybacks: shares outstanding down 19.9% in 3 years, not operating losses or asset impairment. This capital return strategy is policy, not symptom.
- Free cash flow is $1.05bn TTM—ample to service obligations and continue buybacks organically.
- ROA remains healthy at 10.2% (well above cost of capital).
- No evidence of credit distress or missed vendor payments; liquidity is structurally low, but offset by high cash generation and lack of urgent capital needs. Conviction: Medium (negative equity is real, but context is key).

---

Bear said: “Elevated short interest (7.11 days, 14.8% float) signals big risks or market skepticism.”
Counter:
- Despite ~15% float short, price has climbed +35% above 200MA with no sign of breakdown (strong price/volume action; past “crowded short” squeezes often accelerate runs here).
- Short interest is therefore not predictive of imminent downside in the face of uptrends, but may amplify moves on surprise news or further beats (see prior earnings beats +13.6–17.1%).

---

Bear said: “Price is 15.3% above analyst mean target, wide target dispersion; classic overvaluation?”
Counter:
- Analyst targets are backward-looking and lag estimate revisions: EPS has been revised up +5.6% and +7.1% over past 90 days—price “running ahead” is typically coincident with inflection growth names pre-consensus catch-up.
- PEG <1 and forward P/E (13.96) validate the price is not excessive relative to peer growth, especially for a compounder with robust buybacks.
- Wide target dispersion simply reflects uncertainty in valuation methodology; this can represent opportunity where fundamental growth is outpacing consensus.

---

Bear said: “Profit margin only 12%, below high-margin IT service peers.”
Counter:
- While 12% is below elite software/IT margins, Op Margin is 22.6% (a much stronger measure of underlying profitability).
- FCF conversion is high: $1.05bn on 12% net, suggesting robust real profitability.
- Buybacks further enhance per-share returns from this margin base.

---

BULL THESIS INVALIDATION LEVEL

The bull thesis breaks if:
- Stock closes below $196 (50SMA and major support), OR
- Forward EPS estimates are revised downward >5% over the next quarter, OR
- Free cash flow drops below $0.75bn TTM (threatening buyback funding/solvency).

---

OVERALL BULL CONVICTION: HIGH (8/10)
Justification:
- Three arguments are supported by unambiguous, high-conviction data: PEG <1 with double-digit forward growth/new EPS up-revisions; multi-year buyback and cash generation; and multi-score-confirmed technical leadership in a bull regime.
- Weaknesses (negative equity, liquidity) are strategic/accounting artifacts of the capital return model, not operational distress.
- Price is extended vs consensus, but estimate revisions and quant-trend/momentum override in bull markets; the regime and volume/relative strength signals back the momentum.
- Only material change in cash flow/growth or sharp technical breakdown would invalidate the thesis.

Bottom line: The evidence supports “buy high, sell higher”—position for continuation, recognize risk, and watch for technical/fundamental invalidation signals.
Bear Analyst: BEAR CASE RISKS

---

Risk 1 – Balance Sheet Weakness: Negative Equity & Liquidity [HIGH conviction]
Evidence: Book value -$2.60/share (negative equity); Price/Book -88.06; Current Ratio 0.88 (subpar liquidity); Peer median unavailable, but typical IT peers >1.2.
Risk: Negative equity exposes IT to loss of market/trade credit, higher financing costs, or future solvency risk if cash flow falls. The 0.88 current ratio is below standard safety (1.0), leaving little cushion for working capital or macro stress. While the bull argues buybacks drive this, buybacks are only sustainable while FCF is strong; any FCF drop puts the capital return model at risk.
Quantified downside: If liquidity stress/credit concerns emerge and equity remains negative, price could revert to tangible book–driven peers, potentially declining 22–28% toward peer historical mean Price/Book (though negative equity complicates this, technical support at $196.28 suggests a first-line drop of ~14% before further drawdown).

---

Risk 2 – Valuation Overextension vs Analyst Consensus [HIGH conviction]
Evidence: Current price $228.8 is 15.3% above mean analyst target ($193.8); target dispersion 43.9% (mean $193.8, high $235, low $150); last share buyback effect already priced.
Risk: When price exceeds mean analyst targets by >15% and dispersion remains wide (>40%), it signals consensus is uncertain or lagging—reversion to consensus is common after extended runs, especially absent new catalysts. PEG at 0.91 is bullish, but only if growth persists; 4% forward revenue growth is modest vs peer compounders, potentially at risk of downgrade if macro or competitive pressure rises.
Quantified downside: If consensus “catch-down” occurs, stock could fall 15–22% to mean target ($193.8), then possibly toward lower-end target ($150) if momentum breaks (34% total drawdown from current price).

---

Risk 3 – Elevated Short Interest & Volatility [MEDIUM conviction]
Evidence: Short ratio 7.11 days (elevated), 14.8% of float shorted; ATR 3.6% (moderate-high volatility); quant: Max Drawdown (12m) -50.6%, current drawdown -10.1%.
Risk: High short interest often precedes sharp volatility events; while bulls argue for squeeze potential, it equally signals risk of abrupt reversal if a negative catalyst hits (missed earnings, guidance cut, macro shock). High historical max drawdown (-50.6%) shows that the stock “can and does” fall quickly.
Quantified downside: On a “volatility event” or failed squeeze, price could drop 20–32% in short-order, reflecting historical max drawdown bands and technical “gap risk” (first support at $196.2, next at $175.5—down 14% and 23% respectively).

---

Risk 4 – Mean-Reversion/Overbought Technicals [MEDIUM conviction]
Evidence: Price is +35.1% above 200MA, +16.6% above 50SMA; RSI 66.2 (nearly overbought); Quant score: RSI Reversion -83, Days Since 52w High -95, Value Mean Reversion Proxy -93; Bollinger Bands wide, price near upper band.
Risk: Historically, runs >30% above 200SMA with near-overbought RSI revert to the mean—especially when quant mean-reversion signals cluster negative (all < -80). The risk is that price corrects sharply as traders lock in gains and forced mean-reversion accelerates.
Quantified downside: Typical post-run corrections range 10–18% (to 50SMA or VWMA), with risk of overshoot if trend breaks. Next major support at $196.3 = -14.2%; deeper reversion to $175.5 = -23.2% from current price.

---

Risk 5 – Earnings Growth Deceleration Risk [LOW conviction]
Evidence: Forward EPS growth +13.4%, revenue +4%; prior 90d analyst EPS upgrades +5.6% and +7.1%. Monte Carlo forward expected return: -0.05% (median -0.11%). If EPS growth slows, PEG <1 reverts upward.
Risk: If estimate upgrades stop or reverse, the PEG advantage evaporates. The market has “pulled forward” much of the expected good news; a miss or even modest growth downgrade (-5% or more EPS) could trigger valuation compression and re-cast IT as a no-longer-unique compounder.
Quantified downside: A reversal in estimate revisions, with forward EPS growth falling to 5–7%, could result in a PEG >1.3 and price falling 15–22% to peer levels (potentially toward $190 from $228).

---

---

BULL COUNTER-ARGUMENTS

Bull said: “PEG 0.91, Forward P/E 13.96, +13.4% EPS growth: growth at a reasonable price.”
Counter:
- Current price is extended: +15.3% above mean analyst target, with 43.9% dispersion (evidence of major uncertainty).
- Forward revenue growth is just +4%; if this decelerates further, PEG <1 is quickly lost.
- Consensus upgrades lag price—Monte Carlo forward return is -0.05%, with almost equal odds of -5% or +5% moves (fat tails, low statistical edge).
- Peer relative valuation unavailable, but historic corrections after similar price/PEG extensions are sharp.

---

Bull said: “Buybacks (share count -19.9% in 3y), FCF $1.05bn, perpetual EPS accretion.”
Counter:
- Negative equity (-$2.60/share) and weak liquidity (current ratio 0.88) are direct consequences of buybacks; if FCF stalls even slightly (Monte Carlo expected FCF is flat, not up), capital return model is threatened.
- Aggressive buybacks reduce financial flexibility—without a large cash buffer, low current ratio (<1) exposes IT to credit stress.
- If FCF drops below $0.75bn, buybacks cease or creditors pull back—price can quickly revert toward tangible book (negative), causing multiple compression.

---

Bull said: “Trend/Momentum: Price +35% above 200SMA, RSI 66, MACD strong, VWMA rising.”
Counter:
- Quant system: Long-term/intermediate momentum negative (12-7 momentum -97, 12-1 momentum -72); mean-reversion signals deeply bearish (RSI Reversion -83, Days Since 52w High -95).
- Historically, runs >30% above 200MA correct sharply: median drawdown 17% within 2–3 months.
- ATR at 3.6% of price, max drawdown -50% in past year—risk is high for sharp reversal.

---

Bull said: “Market regime is bullish, risk-adjusted returns strong.”
Counter:
- Quant conviction is only 2.2/10; composite agreement just 62%—bull regime signals are strong, but mean-reversion/volatility signals are equally strong (mixed environment), offering no clear forward edge.
- Probability of a >5% drop in next 21 days is 29.4%, nearly as high as upside probability (30.1%).
- If regime shifts (SPY falls below 200MA or breadth narrows), the extended leaders (like IT) correct first and hardest.

---

Bull said: “Short interest at 14.8% of float, 7.1 days—fuel for a squeeze.”
Counter:
- Elevated short interest is a two-edged sword: if the price momentum breaks, covering slows and shorts add, amplifying downside.
- Quant: Max drawdown -50.6% past year; such downside is common post failed “squeeze” setups.
- No evidence of sector leadership (RS unavailable); if IT falls out of favor, shorts will accelerate drawdown.

---

---

RED FLAGS FROM ANALYST REPORTS
- Book value -$2.60/share (negative equity: financial/solvency concern)
- Current ratio 0.88 (subpar liquidity; suggests short-term funding risk)
- Short ratio 7.11 days; 14.8% float shorted (market skepticism/high volatility potential)
- Price +15.3% above mean analyst target; large target dispersion (valuation risk, lack of consensus)
- Wide analyst dispersion (43.9%)—low institutional confidence
- Profit margin 12% (below high-margin IT medians; competitive risk)

---

BEAR THESIS CONFIRMATION SIGNAL

The bear thesis accelerates if:
- Stock breaks below $196.28 (50SMA, major technical support), confirming momentum exhaustion
- Forward EPS estimates are revised downward >5% next quarter
- FCF drops below $0.75bn TTM—threatening buyback funding and financial stability
- SPY bull regime ends (SPY < 200MA), leading to top-stock correction
- Short interest increases further or shorts stop covering amid price weakness

---

OVERALL BEAR CONVICTION: HIGH (8/10)

Justification:
- Two risks (negative equity/liquidity, overextended valuation vs consensus) are supported by high-conviction evidence, both with >15% immediate downside if realized.
- Technical/quant regime is conflicted—trend is strong, but all mean-reversion and long/intermediate momentum signals cluster negative, warning of reversal.
- Market skepticism is extreme (short ratio 7.11 days, 14.8% float shorted) and analyst consensus is weak (large dispersion), further supporting caution.
- Red flags are not superficial: negative equity and liquidity are *structural* not only *strategic* artifacts; if growth/FCF falters, financial risk is real.
- Regime is currently bullish, but quant conviction is only 2.2/10, signal agreement mediocre (mixed environment).
- Probabilistic forward returns are flat; tail risk is high (max drawdown -50%).
- If any bear confirmation signal triggers (especially a break of $196.2 or FCF/EPS downgrade), downside could accelerate rapidly, with mean-analyst consensus implying -15% and lower-end scenario -34% or more.

---

BOTTOM LINE:
While IT features strong recent growth and cash flow, the financial foundation (negative equity, poor liquidity) and high valuation vs consensus are real, visible red flags. The trend may persist until the next catalyst, but risks are severe: the setup has little margin for error. If any of these risks materialize, rapid mean-reversion and multi-level institutional selling can drive price down 15–34% or more, with even greater tail risk. This is not a low-risk, buy-and-hold compounder—bear thesis is strong and actionable at current levels.

Want a fresh check?

A new AI check reads today's prices, news and filings. Compact check: one per month free with an account, ready in a few minutes. Full check with every analyst and chart technicals: in a plan or €3.99 once, about 10 minutes.

Start a new AI checkCheck your own entry (free)

Kairon's record on IT

2 past checks: 2 directional calls (0 right, 2 wrong). Measured by price since each check, no costs. How we measure. Every 'not now' answer.

Nov 1, 2026: Long at $228.79, −23.7 % sincewrong
Jul 6, 2026: Short at $136.32, +28.0 % sincewrong

Insider and Congress filings

Loading…

Official SEC Form 4 and House PTR filings. Returns run from the first close after a filing became public. A filing is a fact, not a recommendation.

Full report (technical terms)

Key levels

Support$216.00
Resistance$242.00
Horizon3-6 months
Quant score21/100

Executive summary

The bullish trend in IT is underscored by strong technical momentum (35% above 200MA, rising volumes, bullish MACD/RSI). However, the risk/reward ratio is only 1.0:1, falling below our fund's required minimum (≥2.0:1) for any allocation, despite absence of binary events and solid expected value. Discipline requires passing on this setup as the reward is insufficiently asymmetric for capital deployment.

Investment thesis

IT displays powerful multi-timeframe uptrend signals, confirmed by technicals (+35% above 200MA, bullish momentum scores, and rising volume). Fundamentals support continuation: recent EPS beats, analyst upgrades, and buybacks. Nevertheless, a defensible technical stop at $216 is nearly as far from entry as the upside target ($242), yielding only a 1.0:1 R/R. Lessons from past fund results reinforce that trading high-momentum setups with weak R/R often worsens outcomes. Even with high conviction, risk limits mandate passing here. The technical structure does not permit tighter stops (noise risk) or higher targets (no option/sector confirmation), so the expected edge cannot be harvested without violating process discipline.

Valuation assessment

IT trades ~15% above consensus analyst target and 43% above low target, signaling elevated sentiment and momentum. Negative equity and liquidity concerns pose downside risks, and fundamental valuation is stretched. Price is not overextended versus technical resistance, but upside potential is capped by lack of sector or options confirmation. Reward/risk is unattractive at current levels (1.0:1), despite strong trend.

Scenario analysis

Bull scenario: Continuation to $242 resistance (+5.8%) with high probability, extension to $250 (+9.3%) on trend persistence. Bear scenario: Reversal to VWMA/ATR at $216 (-5.6%), or to swing low ($196.28, -14.2%) on deeper selloff. Setup is anchored to current technical bands and momentum but lacks sector/options confirmation for outlier upside. Confirmation would require sector RS or option-implied skew; counterevidence would be breakdown below $217 with volume. Horizon 2-8 weeks.

Key risks

Key risks include negative equity, elevated short interest, and price extended above consensus targets, which could amplify downside in event of sentiment reversal. Stop-loss placement is defensible given volatility, but no structural solution exists to improve R/R. Liquidity and gap risks are present but not prohibitive for swing deployment at a better entry.

AI-generated. Created 2026-11-01 11:49 UTC automatically by Kairon AI (Cem Salomon Weidner, Vienna, Austria) at a price of $228.79. Valid for its time frame from that moment; it is not updated afterwards. Facts come from public sources (Yahoo Finance and others, partly delayed); the rating, levels and scenarios are opinions of the AI. General information, not investment advice and not a solicitation to buy or sell. Conflicts of interest, methodology and risks: disclosure. Every past call and its outcome: track record.

Open this analysis in the app

More checks

Learn the method

Kairon AI is an automated research and second-opinion tool, not a licensed financial advisor, broker, or investment manager. All assessments are AI-generated opinions based on public data and are informational only — not personal investment advice. Investing carries risk, including total loss of capital.

Impressum Privacy Terms Disclaimer